{"id":"https://openalex.org/W2954738658","doi":"https://doi.org/10.1158/1538-7445.am2019-331","title":"Abstract 331: Dynamic kinome targeting reveals kinases involved in acquired resistance to tyrosine kinase inhibitors in EGFR-driven glioblastomas","display_name":"Abstract 331: Dynamic kinome targeting reveals kinases involved in acquired resistance to tyrosine kinase inhibitors in EGFR-driven glioblastomas","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W2954738658","doi":"https://doi.org/10.1158/1538-7445.am2019-331","mag":"2954738658"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2019-331","doi":"https://doi.org/10.1158/1538-7445.am2019-331","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-331","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Abby Shelton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abby Shelton","raw_affiliation_strings":["1UNC Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UNC Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001036572","display_name":"Erin Smithberger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erin Smithberger","raw_affiliation_strings":["1UNC Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UNC Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060315102","display_name":"Madison K. Butler","orcid":"https://orcid.org/0000-0002-1031-2054","observed_orcids":["https://orcid.org/0000-0002-1031-2054"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Madison Butler","raw_affiliation_strings":["2NCI, Bethesda, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2NCI, Bethesda, MD;","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110918815","display_name":"\u00c1lex Flores","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex Flores","raw_affiliation_strings":["1UNC Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UNC Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020249243","display_name":"Ryan Bash","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Bash","raw_affiliation_strings":["1UNC Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UNC Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067366916","display_name":"Steven P. Angus","orcid":"https://orcid.org/0000-0002-7655-657X","observed_orcids":["https://orcid.org/0000-0002-7655-657X"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steve Angus","raw_affiliation_strings":["1UNC Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UNC Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014356370","display_name":"Noah Sciaky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Noah Sciaky","raw_affiliation_strings":["1UNC Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UNC Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031163794","display_name":"Harshil Dhruv","orcid":"https://orcid.org/0000-0003-2571-6649","observed_orcids":["https://orcid.org/0000-0003-2571-6649"]},"institutions":[{"id":"https://openalex.org/I1284308235","display_name":"Translational Genomics Research Institute","ror":"https://ror.org/02hfpnk21","country_code":"US","type":"facility","lineage":["https://openalex.org/I1284308235"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harshil Dhruv","raw_affiliation_strings":["3Translational Genomics Research Institute, AZ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Translational Genomics Research Institute, AZ;","institution_ids":["https://openalex.org/I1284308235"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047612906","display_name":"Gary L. Johnson","orcid":"https://orcid.org/0000-0003-2867-0551","observed_orcids":["https://orcid.org/0000-0003-2867-0551"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary L. Johnson","raw_affiliation_strings":["1UNC Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UNC Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055952981","display_name":"Michael E. Berens","orcid":"https://orcid.org/0000-0002-3382-6787","observed_orcids":["https://orcid.org/0000-0002-3382-6787"]},"institutions":[{"id":"https://openalex.org/I1284308235","display_name":"Translational Genomics Research Institute","ror":"https://ror.org/02hfpnk21","country_code":"US","type":"facility","lineage":["https://openalex.org/I1284308235"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael E. Berens","raw_affiliation_strings":["3Translational Genomics Research Institute, AZ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Translational Genomics Research Institute, AZ;","institution_ids":["https://openalex.org/I1284308235"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036985768","display_name":"Frank B. Furnari","orcid":"https://orcid.org/0000-0003-1909-4361","observed_orcids":["https://orcid.org/0000-0003-1909-4361"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frank Furnari","raw_affiliation_strings":["4UC San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4UC San Diego, CA","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032063105","display_name":"C. Ryan Miller","orcid":"https://orcid.org/0000-0002-0096-8762","observed_orcids":["https://orcid.org/0000-0002-0096-8762"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Ryan Miller","raw_affiliation_strings":["1UNC Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UNC Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"79","issue":"13_Supplement","first_page":"331","last_page":"331"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9179999828338623,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9179999828338623,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.055399999022483826,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0052999998442828655,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.7070000171661377},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.9380000233650208},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9449999928474426},{"id":"https://openalex.org/keywords/egfrviii","display_name":"EGFRvIII","score":0.9509999752044678},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.7039999961853027},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/afatinib","display_name":"afatinib","score":0.9879999756813049},{"id":"https://openalex.org/keywords/ntrk3","display_name":"NTRK3","score":0.8960000276565552},{"id":"https://openalex.org/keywords/kinome-reprogramming","display_name":"kinome reprogramming","score":0.6330000162124634},{"id":"https://openalex.org/keywords/cdkn2a-deletion","display_name":"CDKN2A deletion","score":0.7760000228881836},{"id":"https://openalex.org/keywords/chemoproteomics","display_name":"chemoproteomics","score":0.5600000023841858},{"id":"https://openalex.org/keywords/transcriptomic-alterations","display_name":"transcriptomic alterations","score":0.4410000145435333},{"id":"https://openalex.org/keywords/cellular-metabolism","display_name":"cellular metabolism","score":0.7689999938011169},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.5210000276565552}],"concepts":[{"id":"https://openalex.org/C54174078","wikidata":"https://www.wikidata.org/wiki/Q3197188","display_name":"Kinome","level":3,"score":0.9608516693115234},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.7644270062446594},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.7094696760177612},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6445446014404297},{"id":"https://openalex.org/C2780265364","wikidata":"https://www.wikidata.org/wiki/Q5009957","display_name":"CDKN2A","level":3,"score":0.5921392440795898},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5686228275299072},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.5107748508453369},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.44631582498550415},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.4326871633529663},{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.418448805809021},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.3931308388710022},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.3164476454257965},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.30718040466308594},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2662000358104706},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2496805191040039},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.18185725808143616},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1335349977016449}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2019-331","doi":"https://doi.org/10.1158/1538-7445.am2019-331","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2019-331","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2899834042","https://openalex.org/W3112265682","https://openalex.org/W2987346895","https://openalex.org/W2955618965","https://openalex.org/W2899724292","https://openalex.org/W4282962539","https://openalex.org/W4282926448","https://openalex.org/W4282984091","https://openalex.org/W2885064343","https://openalex.org/W4411758138"],"abstract_inverted_index":{"Abstract":[0],"Glioblastoma":[1],"(GBM)":[2],"is":[3,30,41],"a":[4,31,42,136,170,323],"devastating":[5],"primary":[6],"brain":[7],"tumor":[8],"with":[9,36,318],"limited":[10],"treatment":[11,336],"options.":[12],"Extensive":[13],"molecular":[14],"characterization":[15],"has":[16],"revealed":[17],"two":[18,293],"particularly":[19,43],"frequent":[20,49],"mutations:":[21],"CDKN2A":[22],"deletion":[23],"(50-60%)":[24],"and":[25,55,118,140,177,187,237,255,275,304,311],"EGFR":[26,40,63,107,142,200,288],"(40-50%).":[27],"EGFRvIII":[28,97],"(~35%)":[29],"constitutively":[32],"active":[33],"truncation":[34],"mutant":[35],"exons":[37],"2-7":[38],"deleted.":[39],"attractive":[44],"therapeutic":[45,329],"target":[46],"due":[47,71],"to":[48,74,105,135,147,181,203,214,220,285,301,326,376],"activating":[50],"mutations,":[51],"such":[52],"as":[53,94,96,267],"EGFRvIII,":[54],"ready":[56],"availability":[57],"of":[58,82,92,132,138,196,198,252,257,316,386],"multiple":[59],"targeted":[60],"inhibitors.":[61],"Several":[62],"tyrosine":[64,377],"kinase":[65,263,378],"inhibitors":[66,379],"(TKI)":[67],"have":[68,152],"failed":[69],"clinically,":[70],"in":[72,116,119,165,184,190,218,235,238,297,313,373,380],"part":[73],"acquired":[75,374],"resistance.":[76],"To":[77],"mechanistically":[78],"examine":[79,182],"this":[80],"type":[81],"resistance,":[83],"we":[84,168,209],"used":[85,169],"genetically-engineered":[86],"mouse":[87,228],"astrocytes":[88,100,229],"harboring":[89],"homozygous":[90],"deletions":[91],"Cdkn2a,":[93],"well":[95],"(CEv3).":[98],"CEv3":[99,227],"were":[101,270],"made":[102],"intrinsically":[103],"resistant":[104,226,276],"the":[106,185,192,205,262,281,387],"TKI":[108,143,163,201],"gefitinib":[109,125],"or":[110,126,194],"erlotinib":[111,127],"via":[112],"long-term":[113,124],"exposure,":[114],"both":[115,191],"vitro":[117,236],"vivo.":[120],"We":[121,151],"found":[122],"that":[123,155,225,331],"exposure":[128],"conferred":[129],"variable":[130],"levels":[131],"cross":[133],"resistance":[134,164,242,300,375],"panel":[137],"second-":[139],"third-generation":[141],"(\u0394IC50":[144],"1.12-36.1-fold),":[145],"relative":[146],"non-resistant":[148,234],"parent":[149],"lines.":[150],"previously":[153],"shown":[154],"dynamic":[156,282],"kinome":[157,283,307,368],"reprogramming":[158],"may":[159],"be":[160],"responsible":[161],"for":[162,390],"glioblastoma.":[166],"Therefore,":[167],"chemical":[171],"proteomics":[172],"method,":[173],"multiplexed":[174],"inhibitor":[175],"beads":[176],"mass":[178],"spectrometry":[179],"(MIB-MS),":[180],"changes":[183],"expressed":[186,272],"functional":[188],"kinome,":[189],"presence":[193],"absence":[195],"one":[197],"several":[199],"known":[202],"penetrate":[204],"blood-brain":[206],"barrier.":[207],"Additionally,":[208],"performed":[210],"RNA":[211,258],"sequencing":[212],"(RNA-seq)":[213],"inspect":[215],"transcriptomic":[216],"alterations":[217,246],"response":[219,284],"these":[221],"drugs.":[222],"RNA-seq":[223,291,310],"showed":[224],"clustered":[230],"separately":[231],"from":[232],"their":[233],"vivo":[239],"counterparts.":[240],"Acquired":[241],"also":[243],"induced":[244],"transcriptome":[245,264],"governing":[247],"cellular":[248],"metabolism,":[249],"including":[250],"upregulation":[251],"metabolic":[253],"pathways":[254],"downregulation":[256],"processing":[259],"genes.":[260],"Importantly,":[261],"was":[265],"rewired,":[266],"67":[268],"kinases":[269,295,371],"differentially":[271],"across":[273],"parental":[274],"cell":[277],"lines":[278],"(Q<0.001).":[279],"Probing":[280],"afatinib,":[286,302],"an":[287],"TKI,":[289],"using":[290,309],"identified":[292],"potential":[294],"involved":[296,372],"acute,":[298],"adaptive":[299],"Bmx":[303],"Ntrk3.":[305],"Integrated":[306],"profiling":[308],"MIB-MS":[312],"murine":[314],"models":[315],"GBM":[317],"defined":[319],"mutational":[320],"profiles":[321],"provides":[322],"powerful":[324],"framework":[325],"define":[327],"novel":[328],"targets":[330],"could":[332],"significantly":[333],"alter":[334],"current":[335],"paradigms.":[337],"Citation":[338],"Format:":[339],"Abby":[340],"Shelton,":[341],"Erin":[342],"Smithberger,":[343],"Madison":[344],"Butler,":[345],"Alex":[346],"Flores,":[347],"Ryan":[348,365],"Bash,":[349],"Steve":[350],"Angus,":[351],"Noah":[352],"Sciaky,":[353],"Harshil":[354],"Dhruv,":[355],"Gary":[356],"L.":[357],"Johnson,":[358],"Michael":[359],"E.":[360],"Berens,":[361],"Frank":[362],"Furnari,":[363],"C.":[364],"Miller.":[366],"Dynamic":[367],"targeting":[369],"reveals":[370],"EGFR-driven":[381],"glioblastomas":[382],"[abstract].":[383],"In:":[384],"Proceedings":[385],"American":[388],"Association":[389],"Cancer":[391,405],"Research":[392],"Annual":[393],"Meeting":[394],"2019;":[395],"2019":[396],"Mar":[397],"29-Apr":[398],"3;":[399],"Atlanta,":[400],"GA.":[401],"Philadelphia":[402],"(PA):":[403],"AACR;":[404],"Res":[406],"2019;79(13":[407],"Suppl):Abstract":[408],"nr":[409],"331.":[410]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-07-12T00:00:00"}